We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

175 hedge funds and large institutions have $659M invested in Meridian Bioscience Inc in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 60 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

5% more funds holding

Funds holding: 167 → 175 (+8)

0% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 60

5% less capital invested

Capital invested by funds: $696M → $659M (-$37.3M)

49% less call options, than puts

Call options by funds: $1.47M | Put options by funds: $2.87M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
60
Reduced
60
Closed
15
Calls
$1.47M
Puts
$2.87M
Net Calls
-$1.39M
Net Calls Change
-$2.06M

Top Buyers

Rank Fund Capital Flow
1
BCM
Brown Capital Management
Maryland
+$18.7M
2
ICOM
Investment Counselors of Maryland
Maryland
+$4.39M
3
JP Morgan Chase
JP Morgan Chase
New York
+$4.31M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.41M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.07M

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$6.05M
2
PP
Prudential plc
United Kingdom
-$5.45M
3
CPCM
Clifton Park Capital Management
Delaware
-$5.39M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.4M
5
Millennium Management
Millennium Management
New York
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.03M +$4.31M +235,825 New
NFA
27
Nationwide Fund Advisors
Ohio
$3.89M +$2.7M +147,522 +185%
UBS AM
28
UBS AM
Illinois
$3.63M +$1.88M +102,597 +93%
Deutsche Bank
29
Deutsche Bank
Germany
$3.55M +$1.24M +67,912 +49%
Millennium Management
30
Millennium Management
New York
$3.54M -$2.81M -153,553 -43%
Ameriprise
31
Ameriprise
Minnesota
$3.47M +$5.54K +303 +0.1%
GF
32
Gabelli Funds
New York
$3.33M – – –
WBC
33
Westpac Banking Corp
Australia
$3.33M – – –
GAM
34
Gotham Asset Management
New York
$3.11M -$1.63M -89,247 -33%
Invesco
35
Invesco
Georgia
$2.86M +$424K +23,203 +16%
BIM
36
BlackRock Investment Management
Delaware
$2.74M -$24.1K -1,317 -0.8%
EAM
37
Edge Asset Management
Washington
$2.65M +$2.83M +154,798 New
CIS
38
Connors Investor Services
Pennsylvania
$2.59M -$60.5K -3,309 -2%
Goldman Sachs
39
Goldman Sachs
New York
$2.54M +$98.1K +5,368 +4%
New York State Teachers Retirement System (NYSTRS)
40
New York State Teachers Retirement System (NYSTRS)
New York
$2.51M – – –
TCIM
41
TIAA CREF Investment Management
New York
$2.43M -$47.8K -2,617 -2%
GI
42
GAMCO Investors
Connecticut
$2.39M +$18.3K +1,000 +0.7%
TA
43
Teton Advisors
New York
$2.36M – – –
MC
44
Menta Capital
California
$2.13M -$21.4K -1,172 -0.9%
SFM
45
Systematic Financial Management
New Jersey
$2.07M -$337K -18,425 -13%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.93M -$86.9K -4,756 -4%
QCG
47
Quadrant Capital Group
Ohio
$1.91M -$76.8K -4,200 -4%
HighTower Advisors
48
HighTower Advisors
Illinois
$1.91M +$623K +34,080 +44%
KAM
49
Keeley Asset Management
Illinois
$1.91M +$186K +10,155 +10%
RC
50
Randolph Company
Ohio
$1.84M +$181K +9,900 +10%
1
2
3 4 5

VIVO Hedge Fund Activity: Q3 2015 in Review

175 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2015, worth a combined $659M — down 5.4% from $696M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new VIVO positions and 15 closed out — a net gain of 8 holders — while 60 added to existing stakes and 60 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $18.7M. The largest seller was Neuberger Berman Group, cutting an estimated $6.05M.

  • 175 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2015, up from 167 in Q2 2015.
  • Funds reported $659M of Meridian Bioscience Inc stock for Q3 2015, down 5.4% quarter-over-quarter.
  • 23 funds opened new Meridian Bioscience Inc positions in Q3 2015 and 15 closed out, a net change of +8 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2015 was Brown Capital Management, an estimated $18.7M added.
  • The largest Meridian Bioscience Inc seller in Q3 2015 was Neuberger Berman Group, an estimated $6.05M sold.

Based on aggregated 13F filings for Q3 2015.